ProfileOfResearchers

TÃTULO: Effect of bone metastasis on outcomes in the CCTG BR.34 phase II randomized trial of dual immune checkpoint inhibitor (ICI) treatment with or without chemotherapy in high-risk, stage IVA/B NSCLC.
AUTORES: Leitzel, Kim; Ali, Suhail M.; Ding, Keyue; Leighl, Natasha B.; Badillo, Francisco Emilio Vera; Gaudreau, Pierre Olivier; Bradbury, Penelope Ann; Goss, Glenwood D.; Shepherd, Lois E.; Costa, Luis; Suva, Larry J.; Drabick, Joseph J.; Ma, Patrick C.; Joshi, Monika; Polimera, Hyma Vani; Lipton, Allan;
PUBLICAÇÃO: 2022, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 40, NÚMERO: 16

INDEXADO EM:

WOS

TÃTULO: Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer.
AUTORES: Allan Lipton; Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Koestler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman;
PUBLICAÇÃO: 2012, FONTE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 15

INDEXADO EM:

WOS

TÃTULO: Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer
AUTORES: Lindsey Zubritsky; Kim Leitzel; Suhail M Ali; Wolfgang Kstler; Eva Maria Fuchs; Luis Costa; Robert D Knight; Abderrahmane Laadem; Matthew L Sherman; Allan Lipton;
PUBLICAÇÃO: 2012, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 30

INDEXADO EM:

WOS

Links Úteis